Gilead: Q4 Earnings Snapshot

Audio By Carbonatix

FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Tuesday reported fourth-quarter earnings of $1.78 billion.

The Foster City, California-based company said it had net income of $1.42 per share. Earnings, adjusted for one-time gains and costs, were $1.90 per share.

The results exceeded Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.67 per share.

The HIV and hepatitis C drugmaker posted revenue of $7.57 billion in the period, also beating Street forecasts. Nine analysts surveyed by Zacks expected $7.06 billion.

Gilead expects full-year earnings in the range of $7.70 to $8.10 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD